Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06177483
Status:
COMPLETED
Last Update Posted:
2024-04-30
First Post:
2023-12-11
Brief Title:
Bioavailability Evaluation of CurQ Curcumin Formulation
Sponsor:
ESM Technologies LLC
Organization:
ESM Technologies LLC
Study Overview
Official Title:
Bioavailability Evaluation of a Micellar Curcumin Formulation curQ Versus 95 Curcumin Extract in Healthy Individuals
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is intended to evaluate how significantly a proprietary curcumin formulation curQ results in greater bioavailability compared to 95 curcumin extract over a 6-hour time period following a single oral dose in healthy men women
Detailed Description:
This study is intended to evaluate how significantly a proprietary curcumin formulation curQ results in greater bioavailability compared to 95 curcumin extract over a 6-hour time period following a single oral dose in healthy men women Bioavailability will be based upon producing the greatest plasma curcumin concentration AUC Secondarily this study is intended to evaluate the safety and tolerability of the curQ curcumin formulation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None